Xylometazoline APTEO MED 0.5 mg/ml, nasal drops, solution, 10 ml

Xylometazoline APTEO MED  is a drug containing xylometazoline hydrochloride as an active substance . The preparation is a locally acting drug that, by constricting blood vessels, reduces congestion and swelling of the nasal mucosa and the amount of secretion. It makes it easier for patients with a blocked nose to breathe through the nose.

The medicinal product facilitates the outflow of secretions from inflamed paranasal sinuses. By reducing the congestion of the mucous membrane of the nasopharyngeal cavity, it can be used as an adjunct in otitis media. Xylometazoline APTEO MED nasal drops facilitate nasal endoscopy (examination of the nasal cavity).

The effect of Xylometazolin APTEO MED starts within 2 minutes of taking the drug and lasts up to 10 hours.

Xylometazoline APTEO MED is indicated for use in children aged 2 to 11 years.

Excessive nasal congestion occurring during colds, hay fever, allergic rhinitis, sinusitis.

The active substance of Xylometazoline APTEO MED is xylometazoline hydrochloride. One ml of solution contains 0.5 mg of xylometazoline hydrochloride, which corresponds to 0.012 – 0.016 mg/drop (0.014 ± 15%).

The other ingredients of the drug are: sodium chloride, benzalkonium chloride solution, disodium phosphate dihydrate, potassium dihydrogen phosphate, purified water.

• Children aged 2 to 5 years (under adult supervision): 1 or 2 drops of Xylometazolin APTEO MED solution into each nostril 1 to 2 times a day (every 8 to 10 hours). Do not use more than 2 doses of the drug into each nostril per day.
• Children aged 6 to 11 years (under adult supervision): 2 to 4 drops of Xylometazoline APTEO MED solution in each nostril 2 to 3 times a day, as needed. Do not use more than 3 doses of the drug in each nostril per day.
• It is recommended to take the last dose of the medication immediately before bedtime.
• Xylometazolin APTEO MED should not be used for longer than 5 consecutive days.
• Xylometazolin APTEO MED should only be used in the nose (also in otitis media).
• To avoid the spread of infection, a package of the drug should be used by only one patient.
• Xylometazoline APTEO MED should not be used in children under 2 years of age. Use in children aged 2 to 11 years should be under adult supervision.

Always use Xylometazoline APTEO MED exactly as described in the patient information leaflet or as your doctor has told you. If you are not sure, ask your doctor or pharmacist.

• If you are allergic to xylometazoline hydrochloride or any of the other ingredients of this medicine,
• if you have had surgery performed through the nose, e.g. removal of the pituitary gland or surgery involving exposure of the dura mater (brain surgery performed through the nose or mouth),
• if you have narrow-angle glaucoma (increased pressure in the eye),
• if you have very dry nasal mucosa (rhinitis sicca or atrophic rhinitis).